Finance Director - Accounting

Cork, County Cork, Ireland

Auto‑apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, FinanceIndustries

Requirements

Candidates should possess a Bachelor's degree in Accounting or Finance, along with a minimum of 10 years of progressive experience in financial leadership roles, specifically within the pharmaceutical or biotechnology industry. Strong knowledge of US GAAP and SEC reporting requirements is essential, as is demonstrated experience with complex financial modeling and analysis.

Responsibilities

The Finance Director - Accounting will lead the end-to-end collaborations accounting, reporting, and forecasting process, reviewing new collaboration agreements and managing related financial activities. They will be responsible for producing management reporting and business insights for senior leadership, collaborating with Alliance Management, Corporate Development, FP&A, and other business partners to identify continuous improvement opportunities. Furthermore, the Director will lead and develop a high-performing team, coordinate audits, and support other financial activities within the organization.

Skills

US GAAP

SEC Reporting

Financial Modeling

Financial Analysis

Collaboration

Auditing

Forecasting

Management Reporting

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free